Vitamin K2 at 100mg Daily is Unsafe and Should Be Immediately Reduced
The patient's current vitamin K2 dose of 100mg (100,000 mcg) daily is dangerously excessive—approximately 1,000 times higher than typical supplementation doses—and should be immediately reduced to the standard microgram range (45-200 mcg daily). This appears to be a dosing error, as therapeutic vitamin K2 (menaquinone) doses range from 45-720 mcg daily, not milligrams.
Critical Safety Concern
The stated dose of 100mg vitamin K2 daily represents a potentially toxic overdose. Standard vitamin K2 supplementation ranges from:
Even in research settings examining high-dose effects, the maximum studied dose is 720 mcg (0.72mg) daily 4, 2. Your patient's reported 100mg dose is 139-2,222 times higher than evidence-based therapeutic ranges.
No Contraindications with Current Medications
Assuming the dose is corrected to the microgram range, there are no significant drug interactions between vitamin K2 and the patient's current medications:
- Carvedilol, lisinopril, empagliflozin, atorvastatin: None of these medications interact with vitamin K2 5, 6
- The KDOQI guideline specifically addresses vitamin K supplementation only in the context of warfarin and other vitamin K antagonists, which should avoid vitamin K supplements 7
- This patient is not on anticoagulants, so vitamin K2 supplementation is permissible
Recommended Dosing Correction
Immediately verify the actual product label. If the supplement truly contains 100mg vitamin K2 per dose, discontinue it and replace with an appropriate formulation:
- For general bone/cardiovascular health: 100-200 mcg daily (MK-7 form preferred) 2, 8
- For documented vitamin K deficiency or specific cardiovascular risk: Up to 240-720 mcg daily 4, 2, 3
The MK-7 (menaquinone-7) form has superior bioavailability and longer half-life compared to other vitamin K2 forms 2.
Vitamin D3 Component
The vitamin D3 component can be safely continued with this medication regimen 9, 10. Standard supplementation of 1,000-2,000 IU daily is appropriate for most adults, with higher doses (up to 5,000 IU daily for 8-12 weeks) reserved for documented deficiency 9. Monitor 25(OH)D levels to maintain target range of 30-50 ng/mL 9, 11.
Monitoring Considerations
Once corrected to appropriate dosing:
- No specific monitoring required for vitamin K2 at standard doses 12
- Vitamin K2 and D3 have no known toxicity at therapeutic doses 12, 11
- The combination may provide synergistic benefits for bone and cardiovascular health 1, 8
Common Pitfall
This case highlights a critical medication safety issue: confusion between milligrams and micrograms in vitamin supplementation. Always verify supplement labels carefully, as vitamin K2 should be dosed in micrograms (mcg or μg), never milligrams, for routine supplementation.